Latest updates

Stay informed with our latest updates, breaking news, and noteworthy developments. Explore our latest updates here.

October 7, 2024

ImmuneWatch DETECT Model Leads the Field in IMMREP23 TCR-epitope Prediction Challenge

ImmuneWatch is proud to announce that its proprietary TCR-epitope prediction tool, ImmuneWatch DETECT, has achieved top performance in the IMMREP23 benchmark competition.

November 15, 2024

Webinar: Applications of TCR-Epitope Prediction Models

Explore how applying TCR-epitope prediction models can significantly improve the analys of immune responses. Discover how machine learning can identify epitope-specific T-cells.

October 23, 2024

ImmuneWatch is attending SITC 2024

Meet us live in Houston on November 8 - 10

September 23, 2024

Can TCR-Epitope models unlock deeper insights into T-cell responses?

Can TCR-Epitope models unlock deeper insights into T-cell responses? This study, developed computational models (TCR-epitope models) to identify WT1-specific T-cell receptors (TCRs) from immune repertoire data.

September 16, 2024

Applications of TCR-Epitope Prediction Models - Webinar

Join Prof. dr. Pieter Meysman in a webinar on the 24th October exploring the applications of TCR-epitope prediction models in analysing immune responses. Discover how machine learning can identify epitope-specific T-cells, with a live demo of ImmuneWatch DETECT by Dr. Sander Wuyts.

September 2, 2024

We’ve Listened: New Features Added to ImmuneWatch DETECT!

Discover the latest updates to ImmuneWatch DETECT, based on user feedback! New features include HLA information for predicted epitopes, multiple epitope analysis, a beta feature for motif exploration, and a new HTML output option to enhance TCR sequencing data analysis.

June 4, 2024

Introducing ImmuneWatch DETECT: A New Bioinformatics Tool for Finding the Epitope Specificity of your T-cell Receptors

We are thrilled to announce the official launch of ImmuneWatch DETECT, a state-of-the-art bioinformatics tool designed to help researchers uncover the epitope specificity of T-cell receptors (TCRs).

June 4, 2024

ImmuneWatch DETECT Demo at AIRR Community Meeting VII

ImmuneWatch demonstrated their advanced TCR-epitope interaction annotation tool, ImmuneWatch DETECT, at the AIRR Community Meeting VII held from June 3-6, 2024 in Porto.

May 6, 2024

New academic paper: Discovering the Link Between T Cell Receptor Diversity and Herpes Zoster Risk

In a new study led by ImmuneWatch co founders, Prof. Kris Laukens, Prof. Pieter Meysman and Prof. Benson Ogunjimi at the University of Antwerp, researchers have unveiled new insights into how the diversity of T cell receptors (TCRs) influences susceptibility to herpes zoster (HZ), commonly known as shingles.

January 17, 2024

Launching the ImmuneWatch DETECT Early Access Program

Are you ready to change the way you interpret your TCR sequencing data? We’re thrilled to announce the launch of our ImmuneWatch DETECT Early Access Program – a unique opportunity for innovators that are using TCR sequencing.

December 14, 2023

ImmuneWatch Validates their Expertise in TCR Specificity Prediction in an Independent Machine Learning Competition

We are excited to share our recent win in the IMMREP23 Kaggle competition focused on TCR (T-cell receptor) specificity prediction. This win is a testament to our team’s expertise in implementing advanced machine learning in immunology.

October 31, 2023

ImmuneWatch receives Horizon Europe funding in a new innovative European partnership to tackle hurdles in malaria vaccine development

October 6, 2023

Watch out for negative data bias in machine learning

Machine learning, with its potential to revolutionise the field of immunology, isn’t immune to the pitfalls of biased data. That is a cautious lesson discussed in a new academic publication by ImmuneWatch co-founders Prof. Kris Laukens and Prof. Pieter Meysman.

October 6, 2023

Introducing a paradigm shift in TCR-based diagnostics

Each infection, vaccine, cancer cell or autoimmune disease can leave a telltale signature in your collection of T cells, the TCR repertoire. That is a consequence of how your immune system recognises and memorises intruders.

June 12, 2023

New academic paper: Using TCR sequencing and AI to shed light on the intricate dynamics of our immune system during SARS-CoV-2 infection

A new study co-authored by ImmuneWatch’s co-founders, Pieter Meysman, Benson Ogunjimi and Kris Laukens, analysed the role of T cells in the severity of COVID-19 and the specificity of their response to SARS-CoV-2, demonstrating the power of AI in unravelling this complex immune response.

May 31, 2023

Invited keynote speaker: The future of AI for health

After two years HIHR is happy to reconnect again to Flanders Bio and to organise its 12th pitch-edition in Antwerp on May 31, 2023 with Quickfire sessions scheduled the week before.

May 5, 2023

Selected to pitch at Knowledge for Growth

We are excited that our abstract “Implementing Artificial Intelligence in the vaccine development process” has been selected for a pitch at Knowledge for Growth!

April 28, 2023

Keynote: Next Generation Vaccines and Immunotherapy

We are happy to announce that our CTO, Pieter Meysman, has been invited as a speaker at the Cross-Regional Pitch & Match session on Next Generation Vaccines & Immunotherapy.

March 30, 2023

ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

ImmuneWatch, Quantoom Biosciences (“Quantoom”) and UAntwerp (Lab of Experimental Hematology) are delighted to announce a public-private partnership in a project under the “Pandemic Preparedness” call, launched by the University of Antwerp in 2022.

March 27, 2023

ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI

ImmuneWatch, a Belgian university spinoff specialising in monitoring and predicting immune responses, has been awarded an innovation grant of € 94.000 from the city of Antwerp.

February 27, 2023

Pieter and Benson, co-founders of ImmuneWatch receive the GSK Vaccines Award 2022 GSK

We are thrilled to announce that Pieter Meysman (CTO) and Benson Ogunjimi (Medical Director), both co-founders of ImmuneWatch, received the GSK Vaccines 2022 award by the Belgian Royal Academy of Medicine.

February 3, 2023

New academic paper: Benchmarking solutions to the T-cell receptor epitope prediction problem

Predicting the cognate epitope target of a T-cell receptor (TCR) with machine learning has been the subject of many academic studies. It is also something we heavily work on at ImmuneWatch.

November 24, 2022

ImmuneWatch is named as a Deep Tech Pioneer by Hello Tomorrow

We’re thrilled to announce we’ve been named a Deep Tech Pioneer by Hello Tomorrow! From more than 4000 of applications our solution has been selected by a team of experts who saw real potential in our technology. ‍

September 12, 2022

ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers

The Belgian university spin-off received a development grant totalling to € 130.000 to further develop their VaccineWatch platform. The company specialises in monitoring and predicting immune responses using artificial intelligence.

June 24, 2022

ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company

There’s a new start-up in the Flemish field of biotechnology. The University of Antwerp and Antwerp University Hospital announce their new spin-off: ImmuneWatch.

June 15, 2022

ImmuneWatch co-founder Kris Laukens receives scientific award from the AstraZeneca Foundation

Professor Kris Laukens (University of Antwerp / ImmuneWatch) receives an award from the AstraZeneca Foundation, after selection by independent juries of the FWO (Scientific Research Fund) and the FNRS (Fonds de la Recherche Scientifique).

May 18, 2022

ImmuneWatch invited to present at the state of the union of Flanders.bio and VIB during the Young Company Pitches

On the 18th of May 2022, VIB and flanders.bio are organising the 8th edition of their State of the Union. This event is part of the Knowledge for Growth which connects the Belgian life sciences community.

May 5, 2022

Interpretable deep learning in immunology

At ImmuneWatch, we embrace machine learning and (interpretable) deep learning in immunology. Based on T-cell sequencing data, we specialise in predicting what epitope a specific T-cell receptor will bind to.

February 2, 2022

New review on single cell T-cell receptor repertoire analysis

Thinking about interrogating the T-cell response using single-cell sequencing technologies? Good idea! The combination of transcriptomic- and repertoire information can provide novel insight into the functional character of T cell immunity and provides paired αβ TCR repertoire data. ‍

January 25, 2022

Press release: Pre-existing immune cells can predict early response to hepatitis B vaccine

“Immunosequencing of T cells, combined with machine learning techniques, may enable scientists to predict which patients will have early, strong protection against hepatitis B infection following vaccination.”

October 7, 2021

ImmuneWatch selected for “Innovative ideas” pitch

We are happy to announce that we have been selected to pitch our startup at “Immunity for Health 2021” in Ghent on October 14, 2021.

September 9, 2021

Webinar with our CTO Pieter Meysman

Our CTO, Pieter Meysman is invited by Lexogen to give a webinar on the topic of: “Why are Vaccines Effective in Some Individuals but Not in Others?” ‍

June 10, 2021

Z-Healthcare features ImmuneWatch

ImmuneWatch is featured on Z-HealthCare. Watch the video here:

July 11, 2019

Z-innovation features ImmuneWatch

An article and video on Z-innovation mentions ImmuneWatch in November 2019.

November 8, 2018

Roche diagnostics awards research grant to UAntwerp team behind ImmuneWatch

For the 60th anniversary of Roche, Roche Diagnostics Belgium organised a Research Grant Competition where teams competed for a 20K research grant in the area of digital diagnostics. ‍